Salicylic acid-based nanomedicine with self-immunomodulatory activity facilitates microRNA therapy for metabolic skeletal disorders
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Salicylic acid-based nanomedicine with self-immunomodulatory activity facilitates microRNA therapy for metabolic skeletal disorders
Authors
Keywords
Drug delivery, Nanomedicine, Salicylic acid, Self-immunomodulation, Metabolic skeletal disorders
Journal
Acta Biomaterialia
Volume 130, Issue -, Pages 435-446
Publisher
Elsevier BV
Online
2021-06-03
DOI
10.1016/j.actbio.2021.05.024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of miR-21 in Osteoblasts–Osteoclasts Coupling In Vitro
- (2020) Agnieszka Smieszek et al. Cells
- MicroRNA-125a-Loaded Polymeric Nanoparticles Alleviate Systemic Lupus Erythematosus by Restoring Effector/Regulatory T Cells Balance
- (2020) Jiali Zhang et al. ACS Nano
- Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
- (2020) Tracey G. Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers of Osteoporosis: An Update
- (2019) Bushra Parveen et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Aspirin on Top of Anticoagulation in Patients With Concomitant Stable Coronary Artery Disease and Atrial Fibrillation
- (2019) Gilles Lemesle CIRCULATION
- MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs
- (2019) Khatia Gabisonia et al. NATURE
- Synthetic presentation of noncanonical Wnt5a motif promotes mechanosensing-dependent differentiation of stem cells and regeneration
- (2019) Rui Li et al. Science Advances
- Unexpected intracellular biodegradation and recrystallization of gold nanoparticles
- (2019) Alice Balfourier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dose-dependent roles of aspirin and other non-steroidal anti-inflammatory drugs in abnormal bone remodeling and skeletal regeneration
- (2019) Yong Xie et al. Cell and Bioscience
- A bone-targeting delivery system carrying osteogenic phytomolecule icaritin prevents osteoporosis in mice
- (2018) Le Huang et al. BIOMATERIALS
- Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease
- (2018) Hon-Jhe Chen et al. MEDICINE
- miR-21 deficiency inhibits osteoclast function and prevents bone loss in mice
- (2017) Cheng-Hu Hu et al. Scientific Reports
- Osteoblast-Targeting-Peptide Modified Nanoparticle for siRNA/microRNA Delivery
- (2016) Yao Sun et al. ACS Nano
- Combination therapeutics in complex diseases
- (2016) Bing He et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects
- (2016) Xiaojin Zhang et al. Nature Communications
- The Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in Osteoporosis
- (2016) Mengge Sun et al. Biomed Research International
- MiR-26a Rescues Bone Regeneration Deficiency of Mesenchymal Stem Cells Derived From Osteoporotic Mice
- (2015) Yan Li et al. MOLECULAR THERAPY
- The Role of “Bone Immunological Niche” for a New Pathogenetic Paradigm of Osteoporosis
- (2015) Danilo Pagliari et al. Analytical Cellular Pathology
- miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents
- (2014) Volker Baumann et al. Future Medicinal Chemistry
- In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
- (2014) James E. Dahlman et al. Nature Nanotechnology
- The promotion of bone regeneration through positive regulation of angiogenic–osteogenic coupling using microRNA-26a
- (2013) Yan Li et al. BIOMATERIALS
- 2 1 Integrin Regulates Th17 Cell Activity and Its Neutralization Decreases the Severity of Collagen-Induced Arthritis
- (2013) M.-A. El Azreq et al. JOURNAL OF IMMUNOLOGY
- Gene Therapy That Works
- (2013) I. M. Verma SCIENCE
- Peptide-based delivery to bone
- (2012) Kazuhiro Aoki et al. ADVANCED DRUG DELIVERY REVIEWS
- Strategies for controlled delivery of growth factors and cells for bone regeneration
- (2012) Tiffany N. Vo et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis
- (2012) Nan Yang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy
- (2012) Ge Zhang et al. NATURE MEDICINE
- Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
- (2012) Athanasios Anastasilakis Therapeutics and Clinical Risk Management
- Disorders of Bone Remodeling
- (2011) Xu Feng et al. Annual Review of Pathology-Mechanisms of Disease
- MicroRNA therapeutics
- (2011) J A Broderick et al. GENE THERAPY
- Lipid-based systemic delivery of siRNA
- (2009) Yu-Cheng Tseng et al. ADVANCED DRUG DELIVERY REVIEWS
- Specific Binding and Mineralization of Calcified Surfaces by Small Peptides
- (2009) Daniel K. Yarbrough et al. CALCIFIED TISSUE INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now